Cargando…
Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence
BACKGROUND: Sporadic cerebral amyloid angiopathy (sCAA) research of the past decade has increasingly focused on developing biomarkers that allow for an earlier and more accurate sCAA-diagnosis. Considering that sCAA does not have treatment options available (yet), more fundamental questions concerni...
Autores principales: | Abdulrahman, Herrer, Smedinga, Marthe, Verbeek, Marcel M., Klijn, Catharina J.M., Richard, Edo, Perry, Marieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198748/ https://www.ncbi.nlm.nih.gov/pubmed/35404283 http://dx.doi.org/10.3233/JAD-220052 |
Ejemplares similares
-
Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023) -
Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis
por: Jäkel, Lieke, et al.
Publicado: (2021) -
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
por: Vervuurt, Marc, et al.
Publicado: (2023) -
Views on Early Diagnosis of Alzheimer’s Disease Among Dutch Physicians: A Qualitative Interview Study
por: Tromp, Krista, et al.
Publicado: (2021) -
Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: van den Berg, Emma, et al.
Publicado: (2023)